Bioxyne Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other
companies in this sector in Australia:
Innate Immunotherapeutics Ltd
sales of 1.83 million Australian Dollars [US$1.46 million]
(1.66 million Australian Dollars [US$1.32 million]
(1.80 million Australian Dollars [US$1.43 million]
of which 100%
was Dermaportation & ET Technologies).
During the year ended June of 2017, sales at
Bioxyne Limited were A$2.01 million (US$1.60 million).
a very small
increase of 1.7%
versus 2016, when the company's sales were A$1.98 million.